Numbing the scalp may beat opioids for brain surgery pain
NCT ID NCT07425678
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether a scalp nerve block (injecting numbing medicine into the scalp) controls pain better than morphine during and after brain surgery. 62 adults having brain tumor surgery were randomly assigned to receive either a scalp block or morphine. Researchers measured heart rate, blood pressure, pain scores, and opioid use. The goal is to find a safer, more effective way to manage pain and reduce opioid-related side effects.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- scalp nerve block (injection of lidocaine and ropivacaine) versus morphine
- What this could lead to
- If scalp nerve block works better, it could offer a safer way to manage pain during brain surgery, reducing opioid side effects and speeding recovery.
- What could go wrong
- This is a small, completed Phase 4 trial with only 62 participants. Results may not apply to all patients or settings, and nerve blocks carry their own risks like infection or incomplete pain relief.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 4
Runs after approval, following long-term safety and how well the treatment works in everyday use.
- Participants
-
62 people
The number who actually took part.
- Started
-
Jan 2025
- Finished
-
Sep 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 75 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age 18 years to 75 years, * American Society of Anesthesiologists class I-III, * Scheduled for supratentorial craniotomy. Exclusion Criteria: * Patient with Glasgow Coma Score (GCS) of less than 15, * Inability to understand the Visual analog scale (VAS) * Allergic to study drugs (Morphine and local anesthetics) * Patient chronically treated with narcotic medications. * History of Liver dysfunction
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Supratentorial tumors are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Aga Khan University Hospital
Karachi, Sindh, 74800, Pakistan